Genetic heterologous prime–boost vaccination strategies for improved systemic and mucosal immunity

Immunisation route-dependent expression of IL-4/IL-13 can modulate HIV-specific CD8+CTL avidity

(2009) Charani Ranasinghe et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Improving vaccines by targeting antigens to dendritic cells

(2009) Ken Shortman et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Tolerability of Two Sequential Electroporation Treatments Using MedPulser DNA Delivery System (DDS) in Healthy Adults

(2009) Mark Wallace et al.   MOLECULAR THERAPY

Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes

(2008) Rogério S Rosada et al.   BMC IMMUNOLOGY

Is intranasal vaccination a feasible solution for tuberculosis?

(2008) Pramod K Giri et al.   Expert Review of Vaccines

The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?

(2008) Rafick-Pierre Sekaly   JOURNAL OF EXPERIMENTAL MEDICINE

Enhanced Induction of Intestinal Cellular Immunity by Oral Priming with Enteric Adenovirus 41 Vectors

(2008) S.-Y. Ko et al.   JOURNAL OF VIROLOGY

Sequential Priming with Simian Immunodeficiency Virus (SIV) DNA Vaccines, with or without Encoded Cytokines, and a Replicating Adenovirus-SIV Recombinant Followed by Protein Boosting Does Not Control a Pathogenic SIVmac251 Mucosal Challenge

(2008) T. Demberg et al.   JOURNAL OF VIROLOGY

DNA vaccines: ready for prime time?

(2008) Michele A. Kutzler et al.   NATURE REVIEWS GENETICS

Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic

(2008) M. Corbett et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals

(2008) Jun Liu et al.   VACCINE

Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers

(2008) A. Guimarães-Walker et al.   VACCINE

EV02: A Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone

(2008) Sheena McCormack et al.   VACCINE

Vaccination with combination of Fit3L and RANTES in a DNA prime-protein boost regimen elicits strong cell-mediated immunity and antitumor effect

(2008) Shuxia Song et al.   VACCINE

Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization

(2008) Igor M. Belyakov et al.   VIROLOGY